Published in Neurology on February 27, 2001
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med (2011) 3.28
Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke (2011) 3.04
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology (2009) 2.47
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2008) 2.40
Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol (2014) 2.39
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology (2006) 2.06
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology (2010) 2.02
Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke (2012) 1.98
Beta-amyloid, blood vessels, and brain function. Stroke (2009) 1.89
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci (2008) 1.85
Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 1.83
Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (2010) 1.78
Cerebral amyloid angiopathy: a systematic review. J Clin Neurol (2011) 1.77
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Alzheimer disease. Dis Mon (2010) 1.64
COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol (2012) 1.62
Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement (2015) 1.62
Multimodality Review of Amyloid-related Diseases of the Central Nervous System. Radiographics (2016) 1.53
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Recurrent stereotyped episodes in cerebral amyloid angiopathy: response to migraine prophylaxis in two patients. Cerebrovasc Dis Extra (2013) 1.44
Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology (2008) 1.42
Enlarged perivascular spaces and small diffusion-weighted lesions in intracerebral hemorrhage. Neurology (2015) 1.42
COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet (2011) 1.38
Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study. J Neurol Neurosurg Psychiatry (2013) 1.32
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol (2014) 1.27
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology (2013) 1.24
Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol (2009) 1.23
MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke (2010) 1.23
Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2012) 1.20
Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology (2013) 1.20
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke (2012) 1.19
Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke (2008) 1.19
White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology (2013) 1.18
Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings. Neuroradiology (2013) 1.17
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol (2009) 1.16
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke (2014) 1.15
APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis. Neurology (2013) 1.14
Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol (2012) 1.14
Cerebral amyloid angiopathy: emerging concepts. J Stroke (2015) 1.14
Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol (2012) 1.14
Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes. J Neurol Neurosurg Psychiatry (2004) 1.10
Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol (2004) 1.10
Imaging of acute stroke. Nat Rev Neurol (2010) 1.09
International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep (2012) 1.09
Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy. Neurology (2013) 1.04
Cerebral amyloid angiopathy-related hemorrhages. Neurol Sci (2008) 1.03
Microbleed detection using automated segmentation (MIDAS): a new method applicable to standard clinical MR images. PLoS One (2011) 1.03
Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology (2012) 1.03
Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther (2014) 1.02
Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain (2014) 1.01
Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. J Neurol (2008) 1.01
Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol (2011) 1.01
Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology (2014) 0.99
Posterior white matter disease distribution as a predictor of amyloid angiopathy. Neurology (2014) 0.98
Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome. Neuroradiology (2014) 0.96
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol (2012) 0.93
Clinical spectrum, underlying etiologies and radiological characteristics of cortical superficial siderosis. J Neurol (2015) 0.93
Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study. Stroke (2012) 0.93
Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology (2014) 0.92
The pattern and pace of hyperacute hemorrhage expansion. Neurocrit Care (2012) 0.92
Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab (2016) 0.89
Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy. Mol Neurodegener (2011) 0.89
Microinfarct disruption of white matter structure: a longitudinal diffusion tensor analysis. Neurology (2014) 0.89
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysis. Neurology (2016) 0.88
Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathol (2015) 0.87
The characteristics of superficial siderosis and convexity subarachnoid hemorrhage and clinical relevance in suspected cerebral amyloid angiopathy. Cerebrovasc Dis (2015) 0.86
Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the Secondary Intracerebral Hemorrhage Score. AJNR Am J Neuroradiol (2010) 0.86
Intracranial hemorrhage. Am J Respir Crit Care Med (2011) 0.86
Prevalence of cortical superficial siderosis in patients with cognitive impairment. J Neurol (2013) 0.86
Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease. JAMA Neurol (2014) 0.85
White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology (2016) 0.85
Cerebral microbleeds and quality of life in acute ischemic stroke. Neurol Sci (2011) 0.85
Cortical localization of microbleeds in cerebral amyloid angiopathy: an ultra high-field 7T MRI study. J Alzheimers Dis (2015) 0.84
Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals. JAMA Neurol (2015) 0.83
Poor correlation between perihematomal MRI hyperintensity and brain swelling after intracerebral hemorrhage. Neurocrit Care (2011) 0.83
TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer's Disease. Transl Stroke Res (2012) 0.83
Cerebral microbleeds in a multiethnic elderly community: demographic and clinical correlates. J Neurol Sci (2014) 0.82
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami. J Cereb Blood Flow Metab (2015) 0.82
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol (2016) 0.82
Fine Particulate Matter, Residential Proximity to Major Roads, and Markers of Small Vessel Disease in a Memory Study Population. J Alzheimers Dis (2016) 0.82
Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. Lancet Neurol (2016) 0.81
Sporadic cerebral amyloid angiopathy: An important cause of cerebral hemorrhage in the elderly. J Neurosci Rural Pract (2011) 0.81
Cerebral microbleeds: a new dilemma in stroke medicine. JRSM Cardiovasc Dis (2012) 0.81
Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy. Eur Neurol Rev (2012) 0.81
No neuropathological evidence for a direct topographical relation between microbleeds and cerebral amyloid angiopathy. Acta Neuropathol Commun (2015) 0.81
APOE ε variants increase risk of warfarin-related intracerebral hemorrhage. Neurology (2014) 0.80
Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy. Cerebrovasc Dis (2016) 0.80
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology (2006) 3.68
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol (1999) 3.63
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol (2001) 3.46
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology (2007) 3.38
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med (2000) 3.23
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology (2004) 2.85
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med (1995) 2.68
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology (2010) 2.49
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology (2009) 2.47
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2008) 2.40
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2010) 2.39
Course of cerebral amyloid angiopathy-related inflammation. Neurology (2007) 2.33
Comparing proxy and patients' perceptions of patients' functional status: results from an outpatient geriatric clinic. J Am Geriatr Soc (1992) 2.16
White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology (2004) 2.07
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology (2006) 2.06
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology (2010) 2.02
Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology (2002) 1.92
A score to predict early risk of recurrence after ischemic stroke. Neurology (2009) 1.88
Antiplatelet use after intracerebral hemorrhage. Neurology (2006) 1.88
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology (2002) 1.82
Pathogenic effects of D23N Iowa mutant amyloid beta -protein. J Biol Chem (2001) 1.74
Yeast mitochondria contain ATP-sensitive, reversible actin-binding activity. Mol Biol Cell (1994) 1.65
Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology (2009) 1.56
Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis. Neurology (2011) 1.50
Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol (1998) 1.47
Current pharmacotherapy for Alzheimer's disease. Annu Rev Med (2006) 1.45
Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology (2011) 1.43
Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology (2008) 1.42
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation. Mol Cell Biol (1987) 1.29
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology (2005) 1.26
Molecular mechanisms for memory: second-messenger induced modifications of protein kinases in nerve cells. Annu Rev Neurosci (1987) 1.24
Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol (2001) 1.22
Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control study. Neuroepidemiology (1999) 1.22
The Causative Classification of Stroke system: an international reliability and optimization study. Neurology (2010) 1.19
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem (1995) 1.18
A molecular mechanism for long-term sensitization in Aplysia. Nature (1987) 1.16
Physicians' attitudes and practices regarding treatment of HIV-infected patients. South Med J (1992) 1.13
Clinical characteristics of pathologically proved cholesterol emboli to the brain. Neurology (2000) 1.05
Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology (2011) 1.02
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet (1998) 0.99
Cerebral microbleeds and cognitive functioning in the PROSPER study. Neurology (2011) 0.96
Structural studies on a family of cAMP-binding proteins in the nervous system of Aplysia. J Cell Biol (1986) 0.95
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. Am J Med (1995) 0.95
Analysis of megakaryocyte ploidy in rat bone marrow cultures. Blood (1989) 0.94
Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis (2005) 0.94
Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase. Biochim Biophys Acta (1992) 0.92
Alzheimer disease's double-edged vaccine. Nat Med (2003) 0.90
BK virus infection in AIDS. Am J Surg Pathol (2000) 0.90
SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study. J Vasc Interv Neurol (2012) 0.88
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial. Neurology (2009) 0.88
Abundant expression of ras proteins in Aplysia neurons. J Cell Biol (1986) 0.88
Severity of leukoaraiosis determines clinical phenotype after brain infarction. Neurology (2011) 0.88
Research and technology in neurocritical care. Neurocrit Care (2012) 0.86
Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the Secondary Intracerebral Hemorrhage Score. AJNR Am J Neuroradiol (2010) 0.86
In vitro stimulation of megakaryocyte maturation by megakaryocyte stimulatory factor. J Biol Chem (1987) 0.81
Feeding, oviposition and survival of Liriomyza trifolii (Diptera: Agromyzidae) on Bt and non-Bt cottons. Bull Entomol Res (2008) 0.80
Double sequential external shocks for refractory ventricular fibrillation. J Am Coll Cardiol (1994) 0.80
Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy. Ann N Y Acad Sci (2000) 0.79
Distribution of cAMP and cAMP-dependent protein kinases in Aplysia sensory neurons. J Neurosci (1987) 0.79
Outcome markers for clinical trials in cerebral amyloid angiopathy. Amyloid (2001) 0.79
The nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Am J Cardiol (1989) 0.77
Fatal phenformin-associated lactic acidosis. Ann Intern Med (1997) 0.77
Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease. Neurosci Lett (1999) 0.76
Cerebral amyloid angiopathy and apolipoprotein E: bad news for the good allele? Ann Neurol (1997) 0.75
Amyloid angiopathy. Neurology (1997) 0.75
The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy. Amyloid (2001) 0.75
Cyclic adenosine monophosphate-dependent mechanisms induce von Willebrand factor expression in the Dami megakaryoblastic cell line. Blood Coagul Fibrinolysis (1995) 0.75
The professional responsibility for the quality of health care. A discussion of methods. Panel discussion. Bull N Y Acad Med (1976) 0.75
New directions, new dimensions, new decisions--for hospital nursing service. 1. NLN Publ (1966) 0.75
Study uncovers 'unnecessary' long-term stays in a short-term hospital. Hospitals (1967) 0.75
Nurses are key in HIP experiment to cut health care costs. Am J Nurs (1972) 0.75
Observations on the participation of nurses and physicians in chronic care. Bull N Y Acad Med (1973) 0.75
Calcium-channel blockers in systemic hypertension. Curr Probl Cardiol (1987) 0.75
Identification and characterization of a functional receptor for interferon-gamma on a megakaryocytic cell line. Blood (1991) 0.75
Deterrent effects of four neem-based formulations on gravid female boll weevil (Coleoptera: Curculionidae) feeding and oviposition on cotton squares. J Econ Entomol (2004) 0.75
Platelet membrane potentials and their significance in monitoring stimulus response coupling. Soc Gen Physiol Ser (1988) 0.75
Thrombin receptors on human platelets. Methods Enzymol (1992) 0.75
Effects of planting dates on boll weevils (Coleoptera: Curculionidae) and cotton fruit in the subtropics. J Econ Entomol (2005) 0.75
Inappropriate discharges of an implantable cardioverter defibrillator secondary to automatic adjustable gain of atrial tachycardia. Pacing Clin Electrophysiol (1997) 0.75